OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Montelukast Ameliorates Scopolamine-induced Alzheimer’s Disease: Role on Cholinergic Neurotransmission, Antioxidant Defence System, Neuroinflammation and Expression of BDNF
Bhavana Yerraguravagari, Naga Pavani Penchikala, Aravinda Sai Kolusu, et al.
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 8, pp. 1040-1055
Closed Access | Times Cited: 7
Bhavana Yerraguravagari, Naga Pavani Penchikala, Aravinda Sai Kolusu, et al.
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 8, pp. 1040-1055
Closed Access | Times Cited: 7
Showing 7 citing articles:
Drugs repurposing in the experimental models of Alzheimer’s disease
Sheer A. Joodi, Weam W. Ibrahim, Mahmoud M. Khattab
Inflammopharmacology (2025)
Open Access
Sheer A. Joodi, Weam W. Ibrahim, Mahmoud M. Khattab
Inflammopharmacology (2025)
Open Access
Montelukast's potential as a neuroprotective agent against acrylamide induced neurotoxicity: In vivo and computational modelling
Abdulaziz Arif A. Alshammari, Minhajul Arfeen, Abdullah S. Alkhamiss, et al.
Food and Chemical Toxicology (2025), pp. 115448-115448
Closed Access
Abdulaziz Arif A. Alshammari, Minhajul Arfeen, Abdullah S. Alkhamiss, et al.
Food and Chemical Toxicology (2025), pp. 115448-115448
Closed Access
The anti-inflammatory drug Montelukast ameliorates cognitive deficits by rescuing the inflammatory levels in young AD animal models
Mengnan Wu, Yanfen Chen, Weiwei Yao, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Mengnan Wu, Yanfen Chen, Weiwei Yao, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Exploring nanoparticular platform in delivery of repurposed drug for Alzheimer’s disease: current approaches and future perspectives
Snigdha Chakraborty, Sukriti Vishwas, Vancha Harish, et al.
Expert Opinion on Drug Delivery (2024), pp. 1-22
Closed Access | Times Cited: 2
Snigdha Chakraborty, Sukriti Vishwas, Vancha Harish, et al.
Expert Opinion on Drug Delivery (2024), pp. 1-22
Closed Access | Times Cited: 2
Protective effect of leukotriene receptor antagonist, montelukast, against cyclophosphamide-induced placental toxicity via modulation of NLRP3/IL-1β signaling pathway in rats
Walaa Yehia Abdelzaher, Salwa A. Ibrahim, Seham A. Abdel-Gaber, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112700-112700
Closed Access | Times Cited: 1
Walaa Yehia Abdelzaher, Salwa A. Ibrahim, Seham A. Abdel-Gaber, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112700-112700
Closed Access | Times Cited: 1
Saroglitazar, a PPAR α/γ agonist alleviates 3-Nitropropionic acid induced neurotoxicity in rats: Unveiling the underlying mechanisms
Madhuri Suma Jakkamsetti, Aravinda Sai Kolusu, Suma Rongala, et al.
NeuroToxicology (2024) Vol. 105, pp. 131-146
Closed Access
Madhuri Suma Jakkamsetti, Aravinda Sai Kolusu, Suma Rongala, et al.
NeuroToxicology (2024) Vol. 105, pp. 131-146
Closed Access
Levosimendan ameliorates the scopolamine induced cognitive impairment via modulating pCREB/BDNF expression, cholinergic neurotransmission and neuroinflammation
Aravinda Sai Kolusu, Grandhi Sandeep Ganesh, Manogna Nagabhairava, et al.
Research Square (Research Square) (2023)
Open Access
Aravinda Sai Kolusu, Grandhi Sandeep Ganesh, Manogna Nagabhairava, et al.
Research Square (Research Square) (2023)
Open Access
